AAAAAA

   
Results: 1-16 |
Results: 16
ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - FAVORABLE IMPACT OF CHRONIC GRAFT-VERSUS-HOST DISEASE ON SURVIVAL AND RELAPSE
Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S BERISSO G MORDINI N INCAGLIATO M FUGAZZA G SESSAREGO M BACIGALUPO A
Citation: P. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - FAVORABLE IMPACT OF CHRONIC GRAFT-VERSUS-HOST DISEASE ON SURVIVAL AND RELAPSE, Haematologica, 83(10), 1998, pp. 896-903
EARLY PREDICTORS OF TRANSPLANT-RELATED MORTALITY (TRM) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - BLOOD UREA NITROGEN AND BILIRUBIN
Authors: BACIGALUPO A VANLINT BM LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S ZIKOS P LOMBARDI A
Citation: A. Bacigalupo et al., EARLY PREDICTORS OF TRANSPLANT-RELATED MORTALITY (TRM) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - BLOOD UREA NITROGEN AND BILIRUBIN, Experimental hematology, 26(8), 1998, pp. 368-368
THE ASSESSMENT OF THE HEMATOPOIETIC RESERVOIR AFTER IMMUNOSUPPRESSIVETHERAPY (IS) OR BONE-MARROW TRANSPLANTATION (BMT) IN SEVERE APLASTIC-ANEMIA
Authors: MARINA P PIAGGIO G FRASSONI F PITTO A ZIKOS P SESSAREGO M ABATE M VANLINT MT BERISSO G BACIGALUPO A
Citation: P. Marina et al., THE ASSESSMENT OF THE HEMATOPOIETIC RESERVOIR AFTER IMMUNOSUPPRESSIVETHERAPY (IS) OR BONE-MARROW TRANSPLANTATION (BMT) IN SEVERE APLASTIC-ANEMIA, Experimental hematology, 26(8), 1998, pp. 415-415
ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE
Authors: BACIGALUPO A ZIKOS P VANLINT MT VALBONESI M LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BREGANTE S BERISSO G VITALE V SESSAREGO M MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Experimental hematology, 26(5), 1998, pp. 409-414
FOSCARNET VS GANCICLOVIR FOR CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - A RANDOMIZED STUDY
Authors: MORETTI S ZIKOS P VANLINT MT TEDONE E OCCHINI D GUALANDI F LAMPARELLI T MORDINI N BERISSO G BREGANTE S BRUNO B BACIGALUPO A
Citation: S. Moretti et al., FOSCARNET VS GANCICLOVIR FOR CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - A RANDOMIZED STUDY, Bone marrow transplantation, 22(2), 1998, pp. 175-180
LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINE VS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE
Authors: ZIKOS P VANLINT MT FRASSONI F LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINE VS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Bone marrow transplantation, 21, 1998, pp. 38-38
ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FAVORABLE IMPACTOF CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) ON SURVIVAL AND RELAPSE
Authors: ZIKOS PM VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S BERISSO G MORDINI N INCAGLIATO M FUGAZZA G SESSAREGO M VITALE V BARRA S CORVO R BACIGALUPO A
Citation: Pm. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FAVORABLE IMPACTOF CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) ON SURVIVAL AND RELAPSE, Bone marrow transplantation, 21, 1998, pp. 39-39
ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE
Authors: BACIGALUPO A ZIKOS P VANLINT MT VALBONESI M LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BREGANTE S BERISSO G VITALE V SESSAREGO M MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 40-40
UNMANIPULATED TRANSPLANTS FROM 1-2-ANTIGEN MISMATCHED FAMILY DONORS
Authors: BACIGALUPO A VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S LOMBARDI A ZIKOS P
Citation: A. Bacigalupo et al., UNMANIPULATED TRANSPLANTS FROM 1-2-ANTIGEN MISMATCHED FAMILY DONORS, Bone marrow transplantation, 21, 1998, pp. 121-121
THIOTEPA CYCLOPHOSPHAMIDE (THIO-CY) AS CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - REDUCING THE DOSE FOR PATIENTS AGED 45 TO 60 YEARS
Authors: BACIGALUPO A VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S LOMBARDI A ZIKOS P
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE (THIO-CY) AS CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - REDUCING THE DOSE FOR PATIENTS AGED 45 TO 60 YEARS, Bone marrow transplantation, 21, 1998, pp. 357-357
A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT)
Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Bone marrow transplantation, 21, 1998, pp. 490-490
THYROID ABNORMALITIES AFTER BMT FOR HEMATOLOGICAL DISORDERS
Authors: COHEN A ROVELLI A UDERZO C PARODI L ARRIGO C VANLINT MT BERISSO G GRASSO L BACIGALUPO A
Citation: A. Cohen et al., THYROID ABNORMALITIES AFTER BMT FOR HEMATOLOGICAL DISORDERS, Bone marrow transplantation, 21, 1998, pp. 568-568
LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINEVERSUS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE
Authors: ZIKOS P VANLINT MT FRASSONI F LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S DESTEFANO F SORACCO M VITALE V BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINEVERSUS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Blood, 91(9), 1998, pp. 3503-3508
THE ASSESSMENT OF THE HEMATOPOIETIC RESERVOIR AFTER IMMUNOSUPPRESSIVETHERAPY OR BONE-MARROW TRANSPLANTATION IN SEVERE APLASTIC-ANEMIA
Authors: PODESTA M PIAGGIO G FRASSONI F PITTO A ZIKOS P SESSAREGO M ABATE M VANLINT MT BERISSO G BACIGALUPO A
Citation: M. Podesta et al., THE ASSESSMENT OF THE HEMATOPOIETIC RESERVOIR AFTER IMMUNOSUPPRESSIVETHERAPY OR BONE-MARROW TRANSPLANTATION IN SEVERE APLASTIC-ANEMIA, Blood, 91(6), 1998, pp. 1959-1965
EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR ON SECRETION OF PROLACTIN, GROWTH-HORMONE, THYROID-STIMULATING HORMONE, AND CORTISOL IN HUMANS
Authors: BARRECA T GOBBI M FRANCESCHINI R BERISSO G VALLEBELLA E CORSINI G CATALDI A ROLANDI E
Citation: T. Barreca et al., EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR ON SECRETION OF PROLACTIN, GROWTH-HORMONE, THYROID-STIMULATING HORMONE, AND CORTISOL IN HUMANS, Current therapeutic research, 58(2), 1997, pp. 88-92
RELAPSE AFTER ALLOGENEIC BMT FOR CML MAY BE SUSTAINED BY A LOW NUMBEROF LEUKEMIC STEM-CELLS
Authors: PODESTA M PIAGGIO G PITTO A FUGAZZA G MORDINI N BERISSO G SORACCO M SESSAREGO M ZIKOS P BACIGALUPO A FRASSONI F
Citation: M. Podesta et al., RELAPSE AFTER ALLOGENEIC BMT FOR CML MAY BE SUSTAINED BY A LOW NUMBEROF LEUKEMIC STEM-CELLS, Blood, 90(10), 1997, pp. 4011-4011
Risultati: 1-16 |